The Primary Care POC Diagnostics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for primary care POC diagnostics has seen robust growth of late. The market, which was valued at $16.46 billion in 2024, is projected to increase to $17.78 billion in 2025, with a CAGR of 8.0%.
The Primary Care POC Diagnostics market is projected to grow to a market size of $23.86 billion in 2029, with a compound annual growth rate (CAGR) of 7.6%.
Download Your Free Sample of the 2025 Primary Care POC Diagnostics Market Report and Uncover Key Trends Now!The drivers in the primary care poc diagnostics market are:
• The rising prevalence of chronic diseases
• The shift towards personalized medicine
• Increase in healthcare expenditure
• Supportive regulatory frameworks and fast-tracked approval processes
• A focus on early disease detection and prevention strategies
The primary care POC diagnostics market covered in this report is segmented –
1) By Product: Glucose Monitoring, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy And Fertility Testing Products, Tumor Or Cancer Marker Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-Of-Abuse (DOA) Testing Products, Other Products
2) By Prescription: Prescription Based, Over-The-Counter (OTC) Testing
3) By End-Use: Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, Other End-Uses
The trends in the primary care poc diagnostics market are:
• The integration of artificial intelligence (AI) and machine learning algorithms into primary care POC diagnostics is an emerging trend.
• Advancements in molecular diagnostics technologies are increasingly influencing the market.
• There is a notable trend towards the miniaturization and portability of POC diagnostic devices.
• The use of multiplexing and panel testing in POC diagnostics is gaining traction.
The major players in the primary care poc diagnostics market are:
• Hoffmann-La Roche Ltd.
North America was the largest region in the primary care POC diagnostics market in 2024